Amphastar Pharmaceuticals EBITDA Margin 2012-2024 | AMPH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Amphastar Pharmaceuticals ebitda margin from 2012 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Amphastar Pharmaceuticals EBITDA Margin 2012-2024 | AMPH

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Profit Margins Gross Margin Operating Margin EBITDA Margin Pre-Tax Margin Net Margin

Amphastar Pharmaceuticals ebitda margin from 2012 to 2024. Ebitda margin can be defined as earnings before interest, taxes, depreciation and amortization as a portion of total revenue.

Related Stocks
Company Name	Market Cap
Teva Pharmaceutical Industries (TEVA)	$20.1B
Dr Reddy's Laboratories (RDY)	$13.1B
BridgeBio Pharma (BBIO)	$5B
Bausch Health Cos (BHC)	$3B
Supernus Pharmaceuticals (SUPN)	$1.8B
Taysha Gene Therapies (TSHA)	$449M
Personalis (PSNL)	$315M
Assembly Biosciences (ASMB)	$117M
Acasti Pharma (ACST)	$28M
Sol-Gel Technologies (SLGL)	$20M
Evoke Pharma (EVOK)	$4M
Teligent (TLGT)	$0M